# Apse

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apse

- Industry: Biotechnology
- Headquarters: St. Louis, US
- Website: www.apsellc.com
- Total disclosed funding: $1.3M
- Latest round: Series A (Sep 11, 2014)
- Investors on record: 2

## About

Apse, LLC specializes in providing innovative software applications and integrated hardware systems, catering to diverse industries such as healthcare, finance, and manufacturing. The company focuses on enhancing operational efficiency and regulatory compliance.Apse, LLC is a technology firm based in St. Louis, US, founded to address complex operational challenges. The company raised USD 1.32 mn in Series A funding on September 11, 2014, from BioGenerator and Helix Ventures. The total amount raised by the company is USD 1.32 mn, leading to a current company valuation of USD 14.78 mn.Apse, LLC specializes in delivering innovative solutions tailored to meet the diverse needs of its clientele. The company primarily focuses on a suite of advanced products, which include software applications and integrated hardware systems designed for performance in various industries. These offerings cater to sectors such as healthcare, finance, and manufacturing, addressing challenges like data management and operational efficiency. Apse, LLC serves a broad client base, including mid-sized enterprises and large corporations in North America and Europe, enabling enhanced data analytics capabilities and streamlined operations.Revenue for Apse, LLC is generated through a combination of subscription services and direct sales. Engaging in B2B transactions, the company provides its products and services to corporate clients who rely on its solutions for operational needs. The pricing structure accommodates varying client requirements, encompassing tiered subscription plans for software features and support services. Clients typically enter into contracts that include both upfront fees and recurring payments, ensuring a continuous revenue stream for Apse, LLC. Key offerings contribute significantly to the firm’s overall financial performance.In September 2014, Apse, LLC raised USD 1.32 mn in Series A funding to support its future growth initiatives. The company is focused on launching new products designed to enhance operational efficiency across its client base, with specific release dates to be determined. Plans for expansion include targeting new markets in North America and Europe, with a strategic focus on broadening its client reach by 2025. The funding will support the development of these initiatives, aligning with the company's goal of providing comprehensive solutions tailored to evolving industry needs.

## Funding rounds

- Series A, Sep 11, 2014, $1.3M — Helix Ventures, BioGenerator

## Investors

- Helix Ventures (https://capitalatlas.ai/funds/helix-ventures) — Series A
- BioGenerator (https://capitalatlas.ai/funds/biogenerator) — Series A